We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$146M
AUM Growth
-$2.25M
(-1.5%)
Cap. Flow
-$1.85M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
49.44%
Holding
70
New
2
Increased
36
Reduced
2
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$2.36M |
| 2 |
NeoGenomics
NEO
|
+$2.33M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
+$2.16M |
| 4 |
ELGX
Endologix Inc
ELGX
|
+$1.93M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$967K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
+$3.56M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$2.76M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$2.03M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
+$1.63M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.2% |
| 2 | Miscellaneous | 1.5% |
| 3 | Consumer Staples | 1.01% |
| 4 | Financials | 0.29% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celldex Therapeutics
CLDX
$3.02B
| $1.85M | 1.27% |
9,521
+231
| +2% | +$50.3K |
|
27
Vertex Pharmaceuticals
VRTX
$130B
| $1.83M | 1.25% |
16,285
+436
| +3% | +$41.5K |
|
28
HealthStream
HSTM
$867M
| $1.82M | 1.25% |
76,014
+2,093
| +3% | +$52.7K |
|
29
Standard BioTools
LAB
$271M
| $1.82M | 1.25% |
74,482
+2,031
| +3% | +$57.1K |
|
|
CPHD
30
DELISTED
Cepheid Inc
CPHD
| $1.82M | 1.24% |
41,272
+1,140
| +3% | +$48.1K |
|
31
Align Technology
ALGN
$10.4B
| $1.75M | 1.2% |
33,934
+898
| +3% | +$48.9K |
|
|
ABCO
32
DELISTED
Advisory Board Co
ABCO
| $1.69M | 1.15% |
36,226
+972
| +3% | +$47.9K |
|
33
LeMaitre Vascular
LMAT
$1.84B
| $1.67M | 1.14% |
242,968
+6,706
| +3% | +$50.1K |
|
|
STKL
34
DELISTED
SunOpta
STKL
| $1.48M | 1.01% |
122,576
+5,106
| +4% | +$67.3K |
|
35
BioMarin Pharmaceuticals
BMRN
$12.5B
| $1.47M | 1% |
20,325
+573
| +3% | +$37.7K |
|
|
36
Ionis Pharmaceuticals
IONS
$7.85B
| $1.06M | 0.73% |
+27,290
| New | +$967K |
|
37
AngioDynamics
ANGO
$648M
| $958K | 0.66% |
69,822
+2,053
| +3% | +$29.3K |
|
38
Cytokinetics
CYTK
$9.64B
| $581K | 0.4% |
165,046
+3,475
| +2% | +$14.6K |
|
39
Novartis
NVS
$263B
| $571K | 0.39% |
6,774
| – | – |
|
|
ENDP
40
DELISTED
Endo International plc
ENDP
| $558K | 0.38% |
8,161
| – | – |
|
|
PETX
41
DELISTED
Aratana Therapeutics, Inc.
PETX
| $539K | 0.37% |
53,667
+1,433
| +3% | +$17.4K |
|
42
United Therapeutics
UTHR
$21.5B
| $491K | 0.34% |
3,820
| – | – |
|
|
AGN
43
DELISTED
Allergan plc
AGN
| $491K | 0.34% |
+2,035
| New | +$455K |
|
44
Elevance Health
ELV
$90.6B
| $490K | 0.34% |
4,095
| – | – |
|
45
Humana
HUM
$47.6B
| $461K | 0.32% |
3,540
| – | – |
|
46
Viatris
VTRS
$19.1B
| $445K | 0.3% |
9,775
| – | – |
|
47
Bristol-Myers Squibb
BMY
$130B
| $424K | 0.29% |
8,290
| – | – |
|
|
AET
48
DELISTED
Aetna Inc
AET
| $422K | 0.29% |
5,215
| – | – |
|
49
Johnson & Johnson
JNJ
$644B
| $407K | 0.28% |
3,820
| – | – |
|
50
AstraZeneca
AZN
$251B
| $406K | 0.28% |
5,680
| – | – |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, First Light Asset Management held 70 positions worth $146M, down 1.5% from $148M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management's Q3 2014 filing shows 2 new, 36 increased, 2 reduced and 8 closed positions. Its largest new stake was Ionis Pharmaceuticals: 27,290 shares worth $1.06M. The largest sale was VOCERA COMMUNICATIONS, INC., an estimated $3.56M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 92% a quarter earlier, followed by Miscellaneous and Consumer Staples.
- First Light Asset Management's largest Q3 2014 buy was Ionis Pharmaceuticals: 27,290 shares worth $1.06M.
- First Light Asset Management added most to Sanofi in Q3 2014, an estimated $2.36M increase.
- First Light Asset Management's biggest Q3 2014 reduction was Lannett Company, Inc., cutting an estimated $1.63M.
- First Light Asset Management fully exited VOCERA COMMUNICATIONS, INC. in Q3 2014, selling an estimated $3.56M.
- First Light Asset Management's ten largest holdings make up 49% of its $146M portfolio in Q3 2014.
- First Light Asset Management opened 2 new positions and closed 8 in Q3 2014.
- First Light Asset Management's portfolio value fell 1.5% quarter-over-quarter to $146M.
Based on First Light Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.